Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD001888. doi: 10.1002/14651858.CD001888.pub4
Methods A randomised controlled trial was conducted to assess the effectiveness of two mechanical methods of blood conservation in reducing the need for allogeneic red blood cells or coagulation products during cardiac surgery. Patient allocations were generated from random number tables by an independent observer and concealed in sealed opaque envelopes
Participants 256 patients undergoing elective coronary artery bypass surgery were randomly allocated to one of three groups:
  • Group 1 (Autotransfusion group): n=84; M//F=75//9; mean (sd) age = 63.8 (7.8) years

  • Group 2 (Combined intervention group): n=84; M//F=74//10; mean (sd) age = 63. 1 (8.2) years

  • Group 3 (Control group): n=84; M//F=74//10; mean (sd) age = 63.4 (9.1) years

Interventions
  • Group 1: during surgery blood from the operation site was collected in a storage system. At the termination of cardiopulmonary bypass, blood remaining in the bypass circuit was added to the storage system. This blood was then centrifuged using a cell salvage system (Dideco Compact cell saver) leaving a concentrated solution of red blood cells with a haematocrit of 50-60%. This autologous blood was then retransfused to the patient during the intra-operative period.

  • Group 2: were treated with cell salvage and acute normovolaemic haemodilution (ANH). After induction of anaesthesia 10ml/kg of blood was removed from a central venous line while being replaced at the same time with an equivalent volume of modified gelatin (Gelofusine). The Harvest Blood Stream Recovery System, an autologous recovery system, was used to remove blood. The recovered blood was stored at room temperature.

  • Group 3: were treated without the use of cell salvage or acute normovolaemic haemodilution (ANH).

Outcomes Outcomes reported: number of patients transfused allogeneic blood, number of patients receiving any blood product, amount of allogeneic blood transfused, blood loss, reoperation for bleeding, hospital length of stay, infection, stroke, renal failure, myocardial infarction
Notes Transfusion threshold: allogeneic red blood cells were transfused in all groups when the haemoglobin level fell below 9.0g/dL
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection bias) Low risk Patient allocations were generated from random number tables by an independent observer
Allocation concealment (selection bias) High risk Allocation concealment was inadequate.
Blinding (performance bias and detection bias)
All outcomes
High risk